Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06440 | 32880477 | Arch Physiol Biochem | High sugar but not high fat diet consumption induces hepatic metabolic disruption and up-regulation of mitochondrial fission-associated protein Drp1 in a model of moderate obesity. | 2020 | Details |
| A06443 | 32880022 | Clin J Gastroenterol | Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06444 | 32879962 | Adv Nutr | A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A06445 | 32879879 | Biomed Res Int | Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study. | 2020 | Details |
| A06447 | 32879136 | JCI Insight | Hepatic lipids promote liver metastasis. | 2020 | Details |
| A06449 | 32878486 | Expert Rev Gastroenterol Hepatol | Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? | 2020 | Details |
| A06454 | 32877213 | Am J Physiol Gastrointest Liver Physiol | High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. | 2020 | Details |
| A06467 | 32868684 | Curr Opin Clin Nutr Metab Care | Dietary protein intake and obesity-associated cardiometabolic function. | 2020 | Details |
| A06468 | 32868653 | Eur J Gastroenterol Hepatol | Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. | 2021 | Details |
| A06469 | 32868652 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. | 2021 | Details |
| A06483 | 32862731 | Int J Food Sci Nutr | Dietary calamondin supplementation slows the progression of non-alcoholic fatty liver disease in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A06485 | 32861753 | Gastrointest Endosc | Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. | 2020 | Details |
| A06486 | 32860311 | Liver Int | The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men. | 2021 | Details |
| A06490 | 32857176 | Eur J Nutr | Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. | 2020 | Details |
| A06492 | 32856322 | J Pharm Pharmacol | Therapeutic effects of açaí seed extract on hepatic steatosis in high-fat diet-induced obesity in male mice: a comparative effect with rosuvastatin. | 2020 | Details |
| A06498 | 32852705 | J Endocrinol Invest | Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease. | 2020 | Details |
| A06501 | 32850903 | Front Med (Lausanne) | Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. | 2020 | Details |
| A06506 | 32849314 | Front Endocrinol (Lausanne) | Fructose Consumption During Pregnancy Influences Milk Lipid Composition and Offspring Lipid Profiles in Guinea Pigs. | 2020 | Details |
| A06508 | 32849284 | Front Endocrinol (Lausanne) | Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. | 2020 | Details |
| A06509 | 32849276 | Front Endocrinol (Lausanne) | Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases. | 2020 | Details |
| A06513 | 32848374 | Clin Interv Aging | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population. | 2020 | Details |
| A06515 | 32846929 | Nutrients | A Traditional Korean Diet Alters the Expression of Circulating MicroRNAs Linked to Diabetes Mellitus in a Pilot Trial. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06523 | 32841326 | J Clin Endocrinol Metab | Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis. | 2020 | Details |
| A06525 | 32841140 | Medicina (B Aires) | [Diagnosis and treatment of non-alcoholic fatty liver disease. Argentine Association for the Study of Liver Diseases, year 2019]. | 2020 | Details |
| A06529 | 32839409 | Biomedicines | Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06536 | 32833552 | J Med Food | Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China. | 2020 | Details |
| A06537 | 32833053 | Langenbecks Arch Surg | Mechanisms of nonalcoholic fatty liver disease and implications for surgery. | 2020 | Details |
| A06538 | 32833043 | Arch Toxicol | A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats. | 2020 | Details |
| A06543 | 32832402 | J Clin Transl Hepatol | NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. | 2020 | Details |
| A06545 | 32831555 | J Family Community Med | Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. | 2020 | Details |
| A06553 | 32827432 | J Clin Endocrinol Metab | Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06559 | 32825154 | Nutrients | The Protective Effect of Myristica fragrans Houtt. Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06567 | 32823983 | J Clin Med | Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. | 2020 | Details |
| A06568 | 32823659 | Int J Mol Sci | Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. | 2020 | Details |
| A06571 | 32823604 | J Clin Med | Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998-2035. | 2020 | Details |
| A06572 | 32822391 | PLoS One | Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06586 | 32819566 | Biochem Biophys Res Commun | Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling. | 2020 | Details |
| A06592 | 32815965 | Food Funct | A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts. | 2020 | Details |
| A06594 | 32814993 | Curr Gastroenterol Rep | Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06599 | 32812776 | Am J Physiol Gastrointest Liver Physiol | An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase. | 2020 | Details |
| A06600 | 32812775 | Am J Physiol Gastrointest Liver Physiol | Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity. | 2020 | Details |
| A06605 | 32810797 | J Nutr Biochem | A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism. | 2020 | Details |
| A06612 | 32808824 | Can J Physiol Pharmacol | Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target. | 2020 | Details |
| A06613 | 32808114 | J Physiol Biochem | Potential roles of bone morphogenetic protein-9 in glucose and lipid homeostasis. | 2020 | Details |
| A06618 | 32805401 | Free Radic Biol Med | Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway. | 2020 | Details |
| A06619 | 32805210 | Chem Biol Interact | High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. | 2020 | Details |
| A06626 | 32802809 | J Hepatocell Carcinoma | Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes. | 2020 | Details |
| A06627 | 32801462 | J Clin Biochem Nutr | Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. | 2020 | Details |
| A06631 | 32800834 | Life Sci | High fructose intake and the route towards cardiometabolic diseases. | 2020 | Details |
| A06638 | 32798334 | Immun Inflamm Dis | Cannabinoid receptor type 1 antagonist inhibits progression of obesity-associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances. | 2020 | Details |
| A06645 | 32796047 | J Epidemiol Community Health | Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study. | 2020 | Details |
| A06646 | 32795560 | Metabolism | Perturbation of the circadian clock and pathogenesis of NAFLD. | 2020 | Details |
| A06647 | 32795504 | Ageing Res Rev | Structure-functional implications of longevity protein p66Shc in health and disease. | 2020 | Details |
| A06653 | 32792584 | Sci Rep | Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity. | 2020 | Details |
| A06660 | 32791310 | Diabetes Metab | Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. | 2020 | Details |
| A06667 | 32788075 | Surg Obes Relat Dis | Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy. | 2020 | Details |
| A06669 | 32786868 | J Agric Food Chem | Fermented Soy Paste Alleviates Lipid Accumulation in the Liver by Regulating the AMPK Pathway and Modulating Gut Microbiota in High-Fat-Diet-Fed Rats. | 2020 | Details |
| A06670 | 32786176 | Zool Res | Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models. | 2020 | Details |
| A06674 | 32785059 | Nutrients | Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. | 2020 | Details |
| A06676 | 32784205 | BMJ Open Gastroenterol | Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2020 | Details |
| A06687 | 32780624 | Metab Syndr Relat Disord | Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes. | 2020 | Details |
| A06693 | 32777485 | Phytomedicine | Cajanolactone A, a stilbenoid from cajanus cajan, prevents ovariectomy-induced obesity and liver steatosis in mice fed a regular diet. | 2020 | Details |
| A06695 | 32777481 | Biochim Biophys Acta Mol Cell Biol Lipids | Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. | 2020 | Details |
| A06701 | 32775971 | EClinicalMedicine | Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database. | 2020 | Details |
| A06702 | 32775350 | Visc Med | The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. | 2020 | Details |
| A06708 | 32774420 | Evid Based Complement Alternat Med | Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats. | 2020 | Details |
| A06710 | 32773176 | HPB (Oxford) | Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. | 2020 | Details |
| A06711 | 32773026 | Biol Aujourdhui | [ER stress and NAFLD]. | 2020 | Details |
| A06713 | 32772909 | Comb Chem High Throughput Screen | Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration. | 2021 | Details |
| A06715 | 32772323 | J Endocrinol Invest | Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. | 2020 | Details |
| A06728 | 32767607 | J Paediatr Child Health | High prevalence of elevated serum liver enzymes in Chinese children suggests metabolic syndrome as a common risk factor. | 2020 | Details |
| A06729 | 32767404 | Cell Biochem Funct | Apoptosis-inducing factor deficient mice fail to develop hepatic steatosis under high fat high fructose diet or bile duct ligation. | 2020 | Details |
| A06731 | 32766474 | Hepatol Commun | Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. | 2020 | Details |
| A06751 | 32759940 | Nutr Diabetes | Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice. | 2020 | Details |
| A06757 | 32758151 | BMC Gastroenterol | Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems. | 2020 | Details |
| A06766 | 32755310 | Am J Physiol Gastrointest Liver Physiol | The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A06767 | 32754976 | Mol Nutr Food Res | Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism. | 2020 | Details |
| A06771 | 32752595 | J Prev Med Public Health | Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women. | 2020 | Details |
| A06772 | 32752277 | Int J Mol Sci | Iron Metabolism in Obesity and Metabolic Syndrome. | 2020 | Details |
| A06775 | 32751794 | Int J Mol Sci | Cold Press Pomegranate Seed Oil Attenuates Dietary-Obesity Induced Hepatic Steatosis and Fibrosis through Antioxidant and Mitochondrial Pathways in Obese Mice. | 2020 | Details |
| A06776 | 32751772 | Nutrients | Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity. | 2020 | Details |
| A06785 | 32746850 | Cell Commun Signal | The crosstalk: exosomes and lipid metabolism. | 2020 | Details |
| A06786 | 32746645 | Expert Rev Gastroenterol Hepatol | Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. | 2020 | Details |
| A06787 | 32745698 | Diabetes Res Clin Pract | Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016. | 2020 | Details |
| A06791 | 32744348 | J Food Biochem | Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high-carbohydrate high-fat diet. | 2020 | Details |
| A06796 | 32742180 | Saudi J Biol Sci | The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06797 | 32742127 | World J Gastroenterol | Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. | 2020 | Details |
| A06798 | 32742124 | World J Gastroenterol | Management of nonalcoholic fatty liver disease in the Middle East. | 2020 | Details |
| A06803 | 32739036 | Am J Med Sci | Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. | 2020 | Details |
| A06804 | 32738842 | J Assoc Physicians India | Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06809 | 32738301 | Biochim Biophys Acta Mol Cell Biol Lipids | Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells. | 2020 | Details |
| A06810 | 32738185 | Mol Nutr Food Res | The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06815 | 32736956 | Nutr Metab Cardiovasc Dis | Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. | 2020 | Details |
| A06817 | 32736293 | Nutr Res | Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. | 2020 | Details |
| A06827 | 32733017 | Sci Rep | Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice. | 2020 | Details |
| A06829 | 32731709 | Wiad Lek | Features of some anthropometric indices and indices of insulin resistance in patients with non-alcoholic steatohepatitis on the background of obesity and osteoarthritis. | 2020 | Details |
| A06831 | 32731119 | Cytokine | Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. | 2020 | Details |